Most brachytherapy centers today use the Phoenix criteria to define clinical success and failure after brachytherapy. But a new paper suggests that brachytherapy can (and perhaps should) use a higher standard for long-term follow-up. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: brachytherapy, outcome, PSA level | 4 Comments »
The news reports today cover studies on:
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: defferred, immediate, MRI-guided biopsy, PSA level, pT0 disease, race, risk, surgery, Treatment | 7 Comments »
In today’s news reports you will find items on:
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment, Uncategorized | Tagged: EBRT, external beam radiation therapy, mitoxantrone, obesity, outcome, prednisone, PSA level | Leave a comment »
Over the years there have been several studies suggesting that regular use of non-steroidal anti-inflammatory agents (NSAIDs) — the most common being aspirin — can decrease prostate inflammation and prostate cancer risk. Since aspirin and other NSAIDs are commonly used to prevent cardiovascular disease, it will be apparent that there is going to be relatively high use of these agents in the men who are also at some degree of risk for prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: aspirin, NSAID, Prevention, PSA level, volume | Leave a comment »
